Autoinflammatory & rare systemic diseases

An association study suggests that PTPN22 and TNFAIP3, but not STAT4, are risk factors for IgG4-related disease

Clin Exp RheumatolPublished association study

Authors' conclusion

Our study identifies the PTPN22 rs2476601C/T and TNFAIP3 rs2230926T/G variants as genetic susceptibility factors for IgG4-RD in the Mexican Mestizo population.

Study context

Population
Patients with a diagnosis of IgG4-related disease and sex-matched healthy controls60 patients with IgG4-related disease (IgG4-RD) and 116 healthy controls
Participants
60 vs 116
Comparison
Allelic and genotypic frequencies of PTPN22, TNFAIP3 and STAT4 variants between cases and controls
  • IgG4-RDn = 60
  • Healthy controlsn = 116
Outcome
STAT4 rs7574865G/T allelic and genotypic frequencies
Methodological detailssex-matched healthy controls (two per patient), TaqMan® genotyping, SNPStats analyses, multifactor dimensionality reduction approach for gene-gene interactions
  • Sex-matched healthy controls (two per patient)
  • TaqMan® genotyping
  • SNPStats analyses
  • Multifactor dimensionality reduction approach for gene-gene interactions

Main finding

As reported in the abstract

  • No statistically significant differences between cases and controls

Further findings

OutcomeEstimateP value
PTPN22 rs2476601C/T association with IgG4-RDCvs TOR (allelic model) 10.2 (95% CI 1.18–88.52)P = 0.009
PTPN22 rs2476601C/T association with IgG4-RDCCvs CTOR (codominant model) 10.6 (95% CI 1.21–93.37)P = 0.009
PTPN22 rs2476601C/T association with IgG4-RDCCvs CT+TTOR (dominant model) 10.6 (95% CI 1.21–93.37)P = 0.009
TNFAIP3 rs2230926T/G association with IgG4-RDTvs GOR 2.75 (95% CI 0.99–7.60)P = 0.04
TNFAIP3 rs2230926T/G association with IgG4-RDTTvs TGOR 2.92 (95% CI 1.03–8.3)P = 0.037
TNFAIP3 rs2230926T/G association with IgG4-RDTTvs TG+GGOR 2.92 (95% CI 1.03–8.3)P = 0.037

Original publication

An association study suggests that PTPN22 and TNFAIP3, but not STAT4, are risk factors for IgG4-related disease. Clin Exp Rheumatol. Published 7 March 2026. doi:10.55563/clinexprheumatol/9c2mfe

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.